Hydrocodone/aspirin
Hydrocodone/aspirin (INNs) is an oral combination drug formulation of the opioid analgesic hydrocodone and the nonsteroidal anti-inflammatory drug (NSAID) aspirin that is used in the treatment of chronic and acute pain.[1] It is sold under brand names including Alor 5/500, Azdone, Damason-P, Lortab ASA, and Panasal 5/500.
Combination of | |
---|---|
Hydrocodone | Opioid analgesic |
Aspirin | NSAIDTooltip nonsteroidal anti-inflammatory drug |
Clinical data | |
Trade names | Alor 5/500, Azdone, Damason-P, Lortab ASA, Panasal 5/500 |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Adverse effects
See also: Aspirin § Adverse effects, and Hydrocodone § Adverse effects
References
- Odom-Forren J, Drain C (11 February 2008). PeriAnesthesia Nursing: A Critical Care Approach. Elsevier Health Sciences. pp. 751–. ISBN 978-1-4377-2610-7.
MORTooltip μ-opioid receptor |
|
---|---|
DORTooltip δ-opioid receptor |
|
KORTooltip κ-opioid receptor |
|
NOPTooltip Nociceptin receptor |
|
Unsorted |
|
Others |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.